1. Home
  2. News
  3. Venmax Drugs & Pharmaceuticals Ltd.
  4. Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
More Venmax Drugs & Pharmaceuticals Ltd. news
Venmax Drugs & Pharmaceuticals Ltd.BSE: VENMAX

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 14, 2026 at 2:56 AM EDT · Issued by Venmax Drugs & Pharmaceuticals Ltd. via BSE India

Filed with BSE · Jul 14, 2026 at 2:56 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/compliances-certificate-under-reg-74-5-of-sebi-dp-regulations-2018-2149

Venmax Drugs & Pharmaceuticals Ltd. on 6ix

Earlier from Venmax Drugs & Pharmaceuticals

  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026Jun 27
  • Closure of Trading WindowJun 27
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026May 6
  • Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.May 6
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026Apr 6

Later from Venmax Drugs & Pharmaceuticals

  • Announcement under Regulation 30 (LODR)-AllotmentJul 29
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 29 2026Jul 29
  • Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.Aug 1
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 01 2026Aug 1
  • Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.Aug 7
All Venmax Drugs & Pharmaceuticals news releases↗

Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.

Follow Venmax Drugs & Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer